LifeLiver

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 28, 2016	Promethera Biosciences	$10.9M Series C Extension	—	Boehringer Ingelheim, Cell Innovation Partners, Fund+, Muneki Handa, SMS Investments, SRIW, Vesalius Biocapital

Total Raised

N/A

Valuation

N/A